Institutional investors purchased a net $35.8 million shares of AZN during the quarter ended March 2016, and now own 10.21% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 14.3 Million shares of AstraZeneca
PRIMECAP MANAGEMENT CO. Bought 12.1 Million shares of AstraZeneca
ARROWSTREET CAPITAL LP Bought 3.0 Million shares of AstraZeneca